Clinical trial
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing…
NCT00427245 · Anglo Celtic Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00427245 |
|---|---|
| Title | Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer |
| Official title | Ovarian Protection Trial In Premenopausal Breast Cancer Patients [OPTION] |
| Lead sponsor | Anglo Celtic Cooperative Oncology Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Infertility, Menopausal Symptoms |
| Intervention type | Drug, Procedure |
| Interventions | cyclophosphamide, goserelin acetate, adjuvant therapy, fertility assessment and management, neoadjuvant therapy |
| Enrollment | 400 |
| Start date | Aug 1, 2004 |
| First posted | Jan 29, 2007 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: